US Stocks

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical is a biopharmaceutical company that develops and commercializes products for treating rare genetic diseases worldwide. Its biologic products include Crysvita, Mepsevii, Dojolvi, and Evkeeza, among others. The company has collaboration and license agreements with different organizations, including Kyowa Kirin Co. and Bayer Healthcare, among others.